MRK

Merck & Co Inc Stock Analysis

NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

$113.87

▼ -1.36%

Latest quote · typically 15 min delayed

$114.64

Open

$114.94

High

$111.57

Low

$115.44

Prev close

$281.24B

Market cap

Guests get 2 analyses/day. .

What you get with ImpliedLens

📊

Financial statements

Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.

🧮

DCF valuation

Customizable discounted cash flow model with live inputs.

🎯

Analyst targets

Price targets, recommendation breakdowns, earnings surprises.

🏦

Institutional context

Ownership data and aggregated FINRA OTC activity.

📋

SEC filings

Direct links to 10-K, 10-Q, 8-K, and proxy statements.

📈

Projection models

Bull/base/bear scenario modeling with editable assumptions.

01Which products and pipeline milestones drive Merck & Co Inc's next five years of cash flow?

02Which risks would invalidate the investment thesis for MRK?

03How does MRK's valuation compare with its growth, quality, and closest alternatives?